30
August 2024
Kobayashi Pharmaceuticals stock skyrockets following online report by Bunshun that the company will go private via MBO (summary translation)
DZH Nihonkabu News
Any examples of strategies, trade ideas, or case studies are intended for illustrative and discussion purposes only, and are not necessarily indicative of the historical or future strategy or performance or the chances of success of any particular strategy. There can be no assurance that investment opportunities described herein will become available in the future. It should not be assumed that any investments described by any models would be profitable if implemented because among other things, assumptions described herein may not materialize. Any specific investments or case studies referenced in this presentation were selected for inclusion herein based on objective, non-performance based criteria solely for the purpose of describing the investment processes and analyses used by Oasis to evaluate such investments. A list of historical investments – including investments that lost money — can be made available upon request. As always, past performance is not necessarily indicative of future results.
30
August 2024
DZH Nihonkabu News
26
August 2024
The Nikkei
22
August 2024
The Nikkei
21
August 2024
Nihon Securities Journal
19
August 2024
FACTA
17
August 2024
The Nikkei
09
August 2024
The Nikkei
08
August 2024
The Nikkei
05
August 2024
DZH Nihonkabu News
04
August 2024
Nikkei Veritas
03
August 2024
Hokkaido Shimbun
02
August 2024
M&A Online
01
August 2024
Reuters
31
July 2024
The Nikkei
30
July 2024
The Nikkei
29
July 2024
The Nikkei
28
July 2024
Business Wire
27
July 2024
Hokkaido Shimbun
25
July 2024
Reuters
25
July 2024
The Nikkei
23
July 2024
The Nikkei
19
July 2024
The Nikkei
15
July 2024
Nikkei Asia
12
July 2024
The Nikkei
12
July 2024
Financial Times
12
July 2024
Reuters
10
July 2024
The Nikkei
08
July 2024
Nikkei Business
05
July 2024
04
July 2024
The Nikkei